XML 98 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Merger and Pre-Merger Financing (Tables)
12 Months Ended
Dec. 31, 2019
Business Combinations [Abstract]  
Summary of assets and liabilities to be sold pursuant to Asset Purchase Agreement
Assets and liabilities of Histogenics on September 27, 2019 were as follows (in thousands):
September 27,
2019
Cash and cash equivalents$302  
Asset held for sale7,000  
Accounts payable(1,106) 
Net assets acquired$6,196